BELANOFF JOSEPH K 4
4 · CORCEPT THERAPEUTICS INC · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
Corcept Therapeutics (CORT) CEO Joseph K. Belanoff Sells Shares
What Happened Joseph K. Belanoff, CEO of Corcept Therapeutics (CORT), reported a planned open-market sale of 12,837 shares on 2026-06-01 at $69.74 per share, grossing about $895,252. Separately, on 2026-05-29 he transferred 300,000 shares without consideration into two 2026 Grantor Retained Annuity Trusts (150,000 shares each).
Key Details
- Transaction dates/prices: 05/29/2026 — gifts/transfers of 300,000 shares (no cash); 06/01/2026 — sale of 12,837 shares at $69.74 ($895,252).
- Shares owned after transaction: not specified in the provided Form 4.
- Notable footnotes: F6 — the 06/01 sale was made under a Rule 10b5‑1 trading plan adopted 11/26/2024; F2–F5 — the 05/29 transfers were to Joseph K. Belanoff and Katherine A. Blenko 2026 Grantor Retained Annuity Trusts (Belanoff is trustee of his trust; spouse is trustee of hers); F1 — reporting person disclaims beneficial ownership of certain trust-held shares except for pecuniary interest.
- Filing: Form 4 filed 2026-06-02 (no late filing flag indicated).
Context
- Gifts/transfers to family trusts are typically estate or tax planning moves and do not necessarily signal a change in views on the company.
- The sale was executed under a pre-established 10b5‑1 plan, which often means the trade was automated/approved in advance and may not reflect the insider’s contemporaneous opinion about the stock.
Insider Transaction Report
Form 4
BELANOFF JOSEPH K
DirectorChief Executive Officer
Transactions
- Gift
Common Stock
[F1]2026-05-29−300,000→ 2,578,326 total(indirect: By Trust) - Gift
Common Stock
[F2][F3]2026-05-29+150,000→ 150,000 total(indirect: By Trust) - Gift
Common Stock
[F4][F5]2026-05-29+150,000→ 150,000 total(indirect: By Trust) - Sale
Common Stock
[F6][F1]2026-06-01$69.74/sh−12,837$895,252→ 2,565,489 total(indirect: By Trust)
Footnotes (6)
- [F1]Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F2]Transfer of shares without consideration to the Joseph K. Belanoff 2026 Grantor Retained Annuity Trust.
- [F3]Shares are held by Joseph K. Belanoff 2026 Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.
- [F4]Transfer of shares without consideration to the Katherine A. Blenko 2026 Grantor Retained Annuity Trust.
- [F5]Shares are held by Katherine A. Blenko 2026 Grantor Retained Annuity Trust, of which the spouse of the Reporting Person is the trustee.
- [F6]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff|2026-06-02